Endovascular myocardial revascularization in a patient after transcatheter aortic valve implantation: a case report

Transcatheter aortic valve implantation (TAVI) is an effective and safe method for treating aortic stenosis (AS), especially in patients at high surgical risk. With the improvement of the quality and increase in life expectancy of the population, comorbid patients with critical AS will increasingly...

Full description

Saved in:
Bibliographic Details
Published inKardiovaskuli͡a︡rnai͡a︡ terapii͡a︡ i profilaktika Vol. 24; no. 7; p. 4461
Main Authors Vasiliev, D. K., Arablinsky, N. A., Zamyatin, R. A., Shukurov, F. B., Feshchenko, D. A., Taliuridze, M. T.
Format Journal Article
LanguageEnglish
Published 17.08.2025
Online AccessGet full text

Cover

More Information
Summary:Transcatheter aortic valve implantation (TAVI) is an effective and safe method for treating aortic stenosis (AS), especially in patients at high surgical risk. With the improvement of the quality and increase in life expectancy of the population, comorbid patients with critical AS will increasingly be encountered in practice, for whom TAVI will be the main method of surgical treatment. Despite the achieved successes in the management of patients with cardiovascular diseases, their cotinuous progression can lead to de novo atherosclerotic lesions or restenosis in the previously stented coronary segment. The design of prosthetic aortic valves used in TAVI can impose a number of technical limitations when repeated coronary interventions are necessary. This article presents a case of successful endovascular treatment of multivessel coronary artery disease guided by intravascular coronary flow assessment in a comorbid patient after TAVI.
ISSN:1728-8800
2619-0125
DOI:10.15829/1728-8800-2025-4461